Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug LYNPARZA app…
New patent expiration for Astrazeneca drug LYNPARZA Read Post »
Annual Drug Patent Expirations for CERDELGA Cerdelga is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Genzyme Corp drug CERDELGA appeared first o…
New patent expiration for Genzyme Corp drug CERDELGA Read Post »
CERDELGA (eliglustat tartrate) Genzyme corp Patent: 7,253,185 Expiration: Apr 29, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dru…
Drug Patent Expirations for the Week of April 24, 2022 Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for COMBIGAN Combigan is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are eleven patents protecting…
The post New patent expiration for Allergan drug COMBIGAN appeared …
New patent expiration for Allergan drug COMBIGAN Read Post »
Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are nine patents protecting this drug. This drug…
The post New patent expiration for The Medicines drug IONSYS appeared first on D…
New patent expiration for The Medicines drug IONSYS Read Post »
COMBIGAN (brimonidine tartrate; timolol maleate) Allergan Patent: 8,133,890 Expiration: Apr 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Exp…
Drug Patent Expirations for the Week of April 17, 2022 Read Post »
COMBIGAN (brimonidine tartrate; timolol maleate) Allergan Patent: 9,474,751 Expiration: Apr 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Exp…
Drug Patent Expirations for the Week of April 17, 2022 Read Post »
Annual Drug Patent Expirations for WELCHOL Welchol is a drug marketed by Daiichi Sankyo Inc and Daiichi Sankyo and is included in four NDAs. It is available from two suppliers.…
The post New patent expiration for Daiichi Sankyo drug WELCHOL appeared fi…
New patent expiration for Daiichi Sankyo drug WELCHOL Read Post »
Annual Drug Patent Expirations for ZOLADEX Zoladex is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Tersera drug ZOLADEX appeared first o…